Monthly Archive: February, 2018

How benign is benign Multiple Sclerosis?

via How benign is benign Multiple Sclerosis?

Is intracerebral haemorrhage worse with prior antiplatelet use?

Association between previous use of antiplatelet therapy and intracerebral hemorrhage outcomes Khan NI, Siddiqui FM, Goldstein JN, et al. Stroke 2017; 48:1810-1817. Abstract BACKGROUND: Although the use of antiplatelet therapy (APT) is associated… Continue reading

What are the promising CSF biomarkers of MND?

The Neurology Lounge┬ástrives hard to keep to the straight and narrow path of clinical neurology. But every now and then it takes a peek at what is happening at the cutting edge of… Continue reading

Ease of access to neurology: the ultimate survey

Is aspirin effective in the prevention of preeclampsia?

Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. Rolnik DL, Wright D, Poon LC, et al. N Engl J Med 2017; 377:613-622. Abstract BACKGROUND: Preterm preeclampsia is an important cause… Continue reading

How effective is brain responsive neurostimulation for intractable epilepsy?

Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy Geller EB, Skarpaas TL, Gross RE, et al. Epilepsia 2017; 58:994-1004. Abstract OBJECTIVE: Evaluate the seizure-reduction response and safety of mesial temporal… Continue reading